Coronavirus: are the UK’s Covid plans out of date amid vaccines successes?
Spending watchdog admits Sunak based cut-heavy spending review on forecasts formulated before trial results were in
Chancellor Rishi Sunak has courted controversy with a freeze on public sector pay rises and a reduction in foreign aid spending in his coronavirus pandemic spending review.
The financial statement “pivoted between largesse and pain”, with Sunak announcing that pay will not increase for around 1.3 million public sector workers due to the economic fallout of Covid-19, the Financial Times reports.
In a statement to MPs yesterday, Sunak said the UK’s “health emergency is not yet over and our economic emergency has only just begun”. But the review has come under fire, after the Office for Budget Responsibility (OBR) revealed that the data used to draw up the plans was published before a string of promising vaccine results emerged.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What figures did the government use?
Tory MPs are “furious” after the spending watchdog admitted that the gloomy “central scenario” forecast on which Sunak’s spending review was based “did not account for the rollout of the immunity jab beginning before Christmas”, the Daily Mail reports.
Under the out-of-date scenario, the OBR predicted that GDP would shrink by 11.3% this year.
This figure, and Sunak’s review, was based on the assumption of “Britain languishing under virus restrictions until next summer”, with pubs and restaurants in many areas of the country remaining closed, the paper adds.
The chancellor presented his review in the Commons yesterday, two days after the announcement that the Oxford/AstraZeneca vaccine has been found to be to 90% effectiveness in certain doses. The encouraging results from ongoing Phase 3 clinical trials have raised hopes that the end of the pandemic could come far sooner than had been expected.
Should the government have adjusted its plans?
It is unclear whether Sunak would have announced different measures had the government used more up-to-date figures. However, the significant differences between the central forecast and other, more optimistic, OBR forecasts might have altered the chancellor’s strategy.
In the OBR’s “best-case scenario” - based on a vaccine being widely available by the spring - GDP “still declines by over 10% this year and the economy takes until the end of next year to recover”, Yahoo! News reports. But in the watchdog’s worst-case scenario, the UK economy shrinks by 12% this year and does not recover until the end of 2024.
In this latter scenario, lockdowns are extended and vaccines prove ineffective.
In a statement yesterday, the OBR said that the announcements last week that the Pfizer-BioNTech and Moderna vaccines have also achieved “excellent results” in late-stage clinical trials “arrived just as our forecasts were being finalised” and was “undoubtedly very positive news”.
“However, it does not automatically imply an immediate or complete return to normal economic life for the whole population for several reasons,” added the watchdog, which predicts lengthier time-scales for producing, sourcing and administering the jabs.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Today's political cartoons - December 22, 2024
Cartoons Sunday's cartoons - the long and short of it, trigger finger, and more
By The Week US Published
-
5 hilariously spirited cartoons about the spirit of Christmas
Cartoons Artists take on excuses, pardons, and more
By The Week US Published
-
Inside the house of Assad
The Explainer Bashar al-Assad and his father, Hafez, ruled Syria for more than half a century but how did one family achieve and maintain power?
By The Week UK Published
-
Jay Bhattacharya: another Covid-19 critic goes to Washington
In the Spotlight Trump picks a prominent pandemic skeptic to lead the National Institutes of Health
By David Faris Published
-
Labour's plan for change: is Keir Starmer pulling a Rishi Sunak?
Today's Big Question New 'Plan for Change' calls to mind former PM's much maligned 'five priorities'
By Sorcha Bradley, The Week UK Published
-
John Prescott: was he Labour's last link to the working class?
Today's Big Quesiton 'A total one-off': tributes have poured in for the former deputy PM and trade unionist
By Harriet Marsden, The Week UK Published
-
Last hopes for justice for UK's nuclear test veterans
Under the Radar Thousands of ex-service personnel say their lives have been blighted by aggressive cancers and genetic mutations
By Sorcha Bradley, The Week UK Published
-
Will Donald Trump wreck the Brexit deal?
Today's Big Question President-elect's victory could help UK's reset with the EU, but a free-trade agreement with the US to dodge his threatened tariffs could hinder it
By Harriet Marsden, The Week UK Published
-
What is the next Tory leader up against?
Today's Big Question Kemi Badenoch or Robert Jenrick will have to unify warring factions and win back disillusioned voters – without alienating the centre ground
By Harriet Marsden, The Week UK Published
-
What is Lammy hoping to achieve in China?
Today's Big Question Foreign secretary heads to Beijing as Labour seeks cooperation on global challenges and courts opportunities for trade and investment
By Harriet Marsden, The Week UK Published
-
Bob Woodward's War: the explosive Trump revelations
In the Spotlight Nobody can beat Watergate veteran at 'getting the story of the White House from the inside'
By Chas Newkey-Burden, The Week UK Published